newsfilter
← Latest News
GlobeNewswire·

Biodesix Announces Third Quarter 2026 Results and Highlights

Delivered total revenue of $24.0 million, an increase of 10% year over year Grew Diagnostic Testing revenue 16% year over year, with test volumes increasing 24% Maintained an 81% gross margin, improved Net loss